86 related articles for article (PubMed ID: 2199617)
1. Small differences, big implications.
Henderson IC
J Clin Oncol; 1990 Aug; 8(8):1297-300. PubMed ID: 2199617
[No Abstract] [Full Text] [Related]
2. New evidence may expand indications for chemotherapy in breast cancer.
Merz B
JAMA; 1989 Sep; 262(9):1153. PubMed ID: 2761048
[No Abstract] [Full Text] [Related]
3. [Adjuvant therapy in breast carcinoma. A specific immunologic preliminary contribution].
Fazio M; Calabrese F; Giacomasso S; Mastromatteo V; Negri L
Minerva Chir; 1988 Sep; 43(18 Suppl):59-62. PubMed ID: 3226597
[No Abstract] [Full Text] [Related]
4. Controversies in the medical management of breast cancer.
Smith IE
Postgrad Med J; 1985 Feb; 61(712):117-22. PubMed ID: 3983039
[No Abstract] [Full Text] [Related]
5. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Jakesz R; Hausmaninger H; Haider K; Kubista E; Samonigg H; Gnant M; Manfreda D; Tschurtschenthaler G; Kolb R; Stierer M; Fridrik M; Mlineritsch B; Steindorfer P; Mittlböck M; Steger G
J Clin Oncol; 1999 Jun; 17(6):1701-9. PubMed ID: 10561206
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic therapy for resectable breast cancer.
Bonadonna G; Valagussa P
J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
[No Abstract] [Full Text] [Related]
7. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
8. [What is the benefit of adjuvant therapy in breast cancer?].
Sauer H
Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
[No Abstract] [Full Text] [Related]
9. Chemotherapy and hormone therapy of metastatic breast cancer.
Paterson AH
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
[No Abstract] [Full Text] [Related]
10. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
[No Abstract] [Full Text] [Related]
12. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
13. Preoperative chemotherapy in primarily inoperable cancer of the breast.
Luboinski G; Nagadowska M; Pienkowski T
Eur J Surg Oncol; 1991 Dec; 17(6):603-7. PubMed ID: 1743309
[TBL] [Abstract][Full Text] [Related]
14. [UFT-MT therapy in advanced or recurrent breast cancer].
Yamaguchi S; Komoriyama H; Tsukikawa S; Imaki S; Morikubo M; Asakura T; Okamura R; Fukuda M; Kanasugi K; Watanabe H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2437-41. PubMed ID: 2124435
[No Abstract] [Full Text] [Related]
15. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
16. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer.
Stotter A
Eur J Surg Oncol; 1999 Aug; 25(4):341-3. PubMed ID: 10419700
[No Abstract] [Full Text] [Related]
17. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
[TBL] [Abstract][Full Text] [Related]
18. Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
Wu CE; Chen SC; Chang HK; Lo YF; Hsueh S; Lin YC
J Formos Med Assoc; 2016 Apr; 115(4):249-56. PubMed ID: 25900861
[TBL] [Abstract][Full Text] [Related]
19. Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.
Rose C; Mouridsen HT; Thorpe SM; Andersen J; Blichert-Toft M; Andersen KW
World J Surg; 1985 Oct; 9(5):765-74. PubMed ID: 4060747
[No Abstract] [Full Text] [Related]
20. The world overview at 10 years: what did we learn about the results of chemotherapy?
Baum M
Recent Results Cancer Res; 1993; 127():163-6. PubMed ID: 8502812
[No Abstract] [Full Text] [Related]
[Next] [New Search]